J S Markowitz, C L DeVane. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Anti-Infective Agents/pharmacologyAntipsychotic Agents/antagonists & inhibitorsAntipsychotic Agents/bloodBenzodiazepinesCiprofloxacin/pharmacologyCytochrome P-450 CYP1A2/biosynthesisCytochrome P-450 CYP1A2/metabolismCytochrome P-450 CYP1A2 InhibitorsDepressive Disorder, Major/metabolismDrug InteractionsDrug Therapy, CombinationEnzyme Inhibitors/pharmacologyEnzyme Repression/drug effectsFemaleHumansMiddle AgedOlanzapinePirenzepine/analogs & derivativesPirenzepine/antagonists & inhibitorsPirenzepine/blood
Substances: See more » Anti-Infective AgentsAntipsychotic AgentsCytochrome P-450 CYP1A2 InhibitorsEnzyme InhibitorsBenzodiazepinesPirenzepineCiprofloxacinCytochrome P-450 CYP1A2Olanzapine
Year: 1999 PMID: 10350045 DOI: 10.1097/00004714-199906000-00023
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN: 0271-0749 Impact factor: 3.153